Nimotuzumab

Categories, Drug Discovery & Development, Immunooncology, Inhibitors and Compound Libraries, Inhibitory Antibodies

Nimotuzumab

Nimotuzumab

Add to cart

Categories: Categories Drug Discovery & Development Immunooncology Inhibitors and Compound Libraries Inhibitory Antibodies Tags: 828933-51-3 angiogenesis EGFR inhibit Inhibitor JAK/STAT signaling Nimotuzumab Tyrosine Kinase/Adaptors Brand: TargetMol

Description

Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).

[accordions]
[accordion title= “Chemical Properties“]

Molecular Weight	N/A
CAS No.	828933-51-3

[/accordion]

HOW CAN WE HELP YOU? Our specialists are to help you find the best product for your application. We will be happy to help you find the right product for the job.

Our Featured Solutions

Animal Models (Preclinical)
Bioprocess
Cell Culture
Cell Imaging & Analysis
Cells & Tissue Repository
Exosome
Growth Factors, Recombinant Proteins
Laboratory Instruments & Equipments
Microfluidics
Western Blotting and Protein Analysis

SERVICES

Customised Soft Hydrogels
Peptide Synthesis Services
DNA Synthesis Services
GMP Industrial/Clinical Lab Set Up
Customized Mouse Model Services
AAV Services
Preclinical and Translational Research
Skin Testing

RESEARCH FIELD

Food & Alternative Protein
Aging & Neuroscience
Cell & Gene Therapy
Drug Discovery & Development
Skin & Personal Care

LEARNING CENTRE

Blog
Technical Content
Product Information

ATLANTIS BIOSCIENCE PTE LTD

362 Upper Paya Lebar Rd, #07-15,
Singapore 534963

+65-8608 0974

[email protected]

LINE info

© 2015-2025 Atlantis Bioscience Pte Ltd. All rights reserved. Co Reg No: 201539516N